WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07F BETA BLOCKING AGENTS, OTHER COMBINATIONS

Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.

Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.


C07FB Beta blocking agents and calcium channel blockers
C07FX Beta blocking agents, other combinations

Combinations of propranolol and hydralazine or dihydralazine are classified in C07FX01.

Last updated: 2018-12-13